Residual marrow damage following therapy with cyclophosphamide
- PMID: 7007067
Residual marrow damage following therapy with cyclophosphamide
Abstract
Studies were performed to determine the type of residual marrow damage which occurs after injecting mice with 200 mg/kg of cyclophosphamide every 2 weeks for 5 courses. Mice treated with cyclophosphamide, and controls injected with normal saline, were studied 6 weeks after the last injection. Complete blood counts, and total nuclear cell counts from femoral marrow revealed no differences between the 2 groups. The number of CFUs in the marrow of cyclophosphamide treated mice was slightly, but significantly, lower than of controls. Cyclophosphamide treated and control mice were then exposed to 300 rad, and the rate of marrow CFUs recovery was determined. That of cyclophosphamide treated mice was significantly slower than that of controls. Stromal function of marrows from cyclophosphamide treated mice was significantly impaired. Also, however, the proliferative potential of marrow CFUs of cyclophosphamide treated mice was modestly reduced relative to that of controls. We conclude that cyclophosphamide treatment of mice results in significant residual marrow damage, due primarily to "stromal" damage, but also to decrease in the proliferative potential of CFUs.
Similar articles
-
[Effect of cyclophosphamide on the bone marrow hematopoiesis in the mouse].Zhonghua Zhong Liu Za Zhi. 1985 Nov;7(6):435-7. Zhonghua Zhong Liu Za Zhi. 1985. PMID: 3836845 Chinese.
-
Late effects of chemotherapy on hematopoietic progenitor cells.Exp Hematol. 1985;13 Suppl 16:49-56. Exp Hematol. 1985. PMID: 3886419
-
Effect of low frequency low energy pulsing electromagnetic fields on mice injected with cyclophosphamide.Exp Hematol. 1991 Mar;19(3):196-201. Exp Hematol. 1991. PMID: 1995311
-
Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).Exp Hematol. 1982 Feb;10(2):206-16. Exp Hematol. 1982. PMID: 7037437
-
Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.Exp Hematol. 1996 Jun;24(7):816-22. Exp Hematol. 1996. PMID: 8647232
Cited by
-
A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide.Cancer Chemother Pharmacol. 1986;18(1):11-6. doi: 10.1007/BF00253055. Cancer Chemother Pharmacol. 1986. PMID: 3757152
-
Expression of assayable residual stem cell damage in erythroid differentiation.Radiat Environ Biophys. 1985;24(2):119-23. doi: 10.1007/BF01229817. Radiat Environ Biophys. 1985. PMID: 4011846
-
Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation.Cancer Chemother Pharmacol. 1989;25(3):213-8. doi: 10.1007/BF00689586. Cancer Chemother Pharmacol. 1989. PMID: 2557172
-
Residual radiation effect in the murine spleen. In situ measurement by 125-iodo-deoxyuridine retention.Radiat Environ Biophys. 1982;20(3):195-200. doi: 10.1007/BF01325468. Radiat Environ Biophys. 1982. PMID: 7051130
-
Assessment of myelotoxicity caused by environmental chemicals.Environ Health Perspect. 1982 Feb;43:129-35. doi: 10.1289/ehp.8243129. Environ Health Perspect. 1982. PMID: 6277616 Free PMC article.